Escin alleviates peripheral neuropathy in streptozotocin induced diabetes in rats
- 1 August 2020
- journal article
- research article
- Published by Elsevier in Life Sciences
- Vol. 254, 117777
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Escin Chemosensitizes Human Pancreatic Cancer Cells and Inhibits the Nuclear Factor-kappaB Signaling PathwayBiochemistry Research International, 2013
- Comparison of metabolic and neuropathy profiles of rats with streptozotocin-induced overt and moderate insulinopeniaNeuroscience, 2010
- Escin, a Pentacyclic Triterpene, Chemosensitizes Human Tumor Cells through Inhibition of Nuclear Factor-κB Signaling PathwayMolecular Pharmacology, 2010
- Minocycline with aspirin: a therapeutic approach in the treatment of diabetic neuropathyNeurological Sciences, 2010
- Effects of escin mixture from the seeds ofAesculus hippocastanumon obesity in mice fed a high fat dietPharmaceutical Biology, 2010
- Pathology and pathogenetic mechanisms of diabetic neuropathy: Correlation with clinical signs and symptomsDiabetes Research and Clinical Practice, 2007
- Aescin: pharmacology, pharmacokinetics and therapeutic profilePharmacological Research, 2001
- A sensitive spectrophotometric method for the determination of superoxide dismutase activity in tissue extractsAnalytical Biochemistry, 1986
- Assay for lipid peroxides in animal tissues by thiobarbituric acid reactionAnalytical Biochemistry, 1979
- Tissue sulfhydryl groupsArchives of Biochemistry and Biophysics, 1959